Related Experiment Video

Updated: Sep 27, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

[Uropediatrics. Update and controversies]

C Miguélez1

  • 1Servicio de Urología Pediátrica, Hospital Materno Infantil, Complejo Hospitalario Carlos Haya, Málaga.

Actas Urologicas Espanolas
|January 2, 2003
PubMed

Insights

This review provides an overview of current Spanish Pediatric Urology (U.P.), updating key aspects like fetal urology, vesicoureteral reflux, and pyeloureteral stenosis for the journal's 25th anniversary.

Area of Science:

  • Pediatric Urology
  • Urology
  • Medical Sciences

Context:

  • Reviewing the 25th anniversary of the Spanish Journal of Urology.
  • Assessing the current landscape of pediatric urology in Spain.
  • Highlighting prevalent and controversial topics in the field.

Purpose:

  • To provide a comprehensive overview of Spanish Pediatric Urology.
  • To update knowledge on key areas including fetal urology, vesicoureteral reflux, and pyeloureteral stenosis.

Summary:

  • The article offers a contemporary perspective on pediatric urology in Spain.
  • It delves into significant issues such as fetal urology, vesicoureteral reflux, and pyeloureteral stenosis.
  • This review serves as an update on the most prevalent and debated topics in pediatric urology.

Impact:

  • Enhances understanding of the current state of pediatric urology in Spain.
  • Provides valuable insights for clinicians and researchers in the field.
  • Contributes to the ongoing discourse on critical pediatric urological conditions.

More Related Videos

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including: